Inovio Pharmaceuticals, Inc. (INO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 39.44M | 61.12M | 55.18M | 52.7M | 71.89M | 97.83M | 91.28M | 117.56M | 111.68M | 153.11M | 174.77M | 203.28M |
| Cash & Short-Term Investments | 37.68M | 58.51M | 50.8M | 47.55M | 68.36M | 94.11M | 84.8M | 110.42M | 105.61M | 145.29M | 167.47M | 194.93M |
| Cash Only | 26.27M | 44.27M | 36.57M | 24.35M | 39.92M | 65.81M | 21.69M | 34.39M | 19.6M | 14.31M | 18.8M | 52.71M |
| Short-Term Investments | 11.41M | 14.24M | 14.24M | 23.2M | 28.45M | 28.3M | 63.12M | 76.03M | 86.01M | 130.98M | 148.67M | 142.21M |
| Accounts Receivable | 0 | 450 | 978.59K | 840.31K | 1.31M | 1.2M | 1.86M | 1.77M | 2.55M | 2.41M | 2.14M | 5.12M |
| Days Sales Outstanding | - | - | - | - | 1.73K | 1.2K | - | 1.95K | - | 2.04K | 859.75 | 2.04K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.43K | 34.92K | 11.93K |
| Total Non-Current Assets | 10.34M | 13.19M | 14.21M | 15.54M | 15.38M | 15.37M | 15.78M | 16.24M | 17.43M | 17.84M | 18.33M | 29.75M |
| Property, Plant & Equipment | 8.33M | 9.07M | 9.7M | 10.45M | 11.09M | 11.77M | 12.56M | 13.33M | 14.17M | 14.45M | 14.73M | 15.79M |
| Fixed Asset Turnover | - | - | - | - | 0.01x | 0.01x | - | 0.01x | - | 0.01x | 0.03x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.51M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 2.1M | 2.5M | 3.09M | 2.31M | 1.61M | 2.64M | 2.32M | 2.65M | 2.78M | 2.99M | 2.78M |
| Other Non-Current Assets | 2.01M | 2.01M | 2.01M | 2.01M | 1.98M | 1.98M | 566.41K | 585.91K | 605.32K | 605.32K | 605.32K | 666.89K |
| Total Assets | 49.78M | 74.31M | 69.39M | 68.24M | 87.27M | 113.2M | 107.06M | 133.8M | 129.11M | 170.95M | 193.1M | 233.04M |
| Asset Turnover | - | - | - | - | 0.00x | 0.00x | - | 0.00x | - | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -42.96% | -34.35% | -35.19% | -49% | -32.41% | -33.78% | -44.56% | -42.59% | -51.57% | -50.95% | -50.74% | -49.27% |
| Total Current Liabilities | 37.92M | 43.67M | 69.82M | 31.71M | 27.33M | 35.33M | 23.5M | 26.4M | 23.4M | 42.57M | 43.71M | 51.93M |
| Accounts Payable | 1.99M | 2.62M | 5.9M | 5.48M | 5.52M | 6.44M | 5.39M | 6.41M | 8.3M | 4.65M | 3.9M | 10.36M |
| Days Payables Outstanding | 278.12 | 519.9 | - | 675.3 | - | 701.31 | - | 807.51 | - | 2.25K | - | - |
| Short-Term Debt | 0 | 0 | 2.74M | 0 | 0 | 0 | 0 | 0 | 0 | 16.77M | 16.49M | 16.71M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 27.02M | 36.44M | 52.44M | 20.08M | 15.86M | 23.26M | 9.92M | 8.66M | 5.71M | 9.95M | 14.04M | 12.52M |
| Current Ratio | 1.04x | 1.40x | 0.79x | 1.66x | 2.63x | 2.77x | 3.88x | 4.45x | 4.77x | 3.60x | 4.00x | 3.91x |
| Quick Ratio | 1.04x | 1.40x | 0.79x | 1.66x | 2.63x | 2.77x | 3.88x | 4.45x | 4.77x | 3.60x | 4.00x | 3.91x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 5.79M | 6.55M | 7.28M | 8M | 8.7M | 9.37M | 10.02M | 10.66M | 11.27M | 11.03M | 11.23M | 11.73M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 5.79M | 6.55M | 7.28M | 8M | 8.7M | 9.37M | 10.02M | 10.66M | 11.27M | 11.03M | 11.19M | 11.7M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.05K | 32.05K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 43.71M | 50.21M | 77.11M | 39.71M | 36.02M | 44.69M | 33.52M | 37.06M | 34.67M | 53.6M | 54.94M | 63.67M |
| Total Debt | 8.7M | 9.37M | 10.02M | 10.66M | 11.27M | 11.87M | 12.45M | 12.98M | 13.43M | 30.21M | 29.8M | 30.76M |
| Net Debt | -17.58M | -34.91M | -26.55M | -13.69M | -28.64M | -53.95M | -9.24M | -21.41M | -6.18M | 15.9M | 11M | -21.95M |
| Debt / Equity | 1.43x | 0.39x | - | 0.37x | 0.22x | 0.17x | 0.17x | 0.13x | 0.14x | 0.26x | 0.22x | 0.18x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | -170.34x | -87.56x | -107.23x | -112.35x |
| Total Equity | 6.07M | 24.1M | -7.72M | 28.53M | 51.25M | 68.5M | 73.54M | 96.74M | 94.44M | 117.35M | 138.16M | 169.37M |
| Equity Growth % | -88.16% | -64.82% | -110.5% | -70.51% | -45.73% | -41.62% | -46.77% | -42.88% | -52.59% | -47.23% | -48.2% | -43.1% |
| Book Value per Share | 0.01 | 0.05 | -0.15 | 0.73 | 1.89 | 2.52 | 2.61 | 3.56 | 4.05 | 5.15 | 6.17 | 7.69 |
| Total Shareholders' Equity | 6.07M | 24.1M | -7.72M | 28.53M | 51.25M | 68.5M | 73.54M | 96.74M | 94.44M | 117.35M | 138.16M | 169.37M |
| Common Stock | 69.77K | 69K | 53.57K | 36.72K | 36.67K | 36.1K | 26.05K | 25.96K | 23.37K | 22.79K | 269.73K | 268.07K |
| Retained Earnings | -1.83B | -1.82B | -1.82B | -1.77B | -1.75B | -1.73B | -1.71B | -1.69B | -1.65B | -1.62B | -1.6B | -1.56B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -636.09K | -637.96K | -647.36K | -661.74K | -661.32K | -675.67K | -623.46K | -689.54K | -676.21K | -662.6K | -751.07K | -691.26K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |